Chongqing Pharscin Pharmaceutical Co Ltd (002907) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Based on the latest financial reports, Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥833.94K ≈ $122.03K USD) by net assets (CN¥1.71 Billion ≈ $250.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002907 net asset quality index to measure how much of total assets are equity-financed.

Chongqing Pharscin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Chongqing Pharscin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Chongqing Pharscin Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Chongqing Pharscin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chongqing Pharscin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cemindo Gemilang Tbk PT JK:CMNT	0.068x
Equites Property Fund Ltd JSE:EQU	0.035x
Forward Industries Inc NASDAQ:FORD	-0.002x
Hangzhou Advance Gearbox Group Co Ltd SHG:601177	0.028x
SmartFinancial, Inc. NYSE:SMBK	0.029x
Ninety One Ltd JSE:NY1	-0.238x
Dongguan Mentech Optical & Magnetic Co Ltd SHE:002902	-0.090x
Nhn Entertain KO:181710	-0.093x

Annual Cash Flow Conversion Efficiency for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Chongqing Pharscin Pharmaceutical Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see 002907 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.66 Billion ≈ $242.91 Million	CN¥161.77 Million ≈ $23.67 Million	0.097x	-28.12%
2023-12-31	CN¥1.62 Billion ≈ $236.75 Million	CN¥219.34 Million ≈ $32.10 Million	0.136x	+1573.59%
2022-12-31	CN¥1.61 Billion ≈ $235.65 Million	CN¥13.04 Million ≈ $1.91 Million	0.008x	-87.62%
2021-12-31	CN¥1.27 Billion ≈ $185.24 Million	CN¥82.85 Million ≈ $12.12 Million	0.065x	-31.94%
2020-12-31	CN¥1.18 Billion ≈ $172.94 Million	CN¥113.64 Million ≈ $16.63 Million	0.096x	+56.20%
2019-12-31	CN¥1.07 Billion ≈ $156.69 Million	CN¥65.92 Million ≈ $9.65 Million	0.062x	+60.48%
2018-12-31	CN¥828.91 Million ≈ $121.30 Million	CN¥31.80 Million ≈ $4.65 Million	0.038x	-66.05%
2017-12-31	CN¥719.95 Million ≈ $105.35 Million	CN¥81.34 Million ≈ $11.90 Million	0.113x	-9.70%
2016-12-31	CN¥461.42 Million ≈ $67.52 Million	CN¥57.73 Million ≈ $8.45 Million	0.125x	-30.78%
2015-12-31	CN¥365.71 Million ≈ $53.51 Million	CN¥66.10 Million ≈ $9.67 Million	0.181x	+167.95%
2014-12-31	CN¥299.77 Million ≈ $43.87 Million	CN¥20.22 Million ≈ $2.96 Million	0.067x	-65.66%
2013-12-31	CN¥240.97 Million ≈ $35.26 Million	CN¥47.34 Million ≈ $6.93 Million	0.196x	--

About Chongqing Pharscin Pharmaceutical Co Ltd

SHE:002907 China Drug Manufacturers - Specialty & Generic

Market Cap

$787.68 Million

CN¥5.38 Billion CNY

Market Cap Rank

#9859 Global

#2526 in China

Share Price

CN¥12.89

Change (1 day)

+1.02%

52-Week Range

CN¥11.69 - CN¥19.08

All Time High

CN¥42.89